BackCannara Biotech Overview

Cannara Biotech Receivables

Cannara Biotech's receivables is $19M.

Get informed when a big investor buys or sells

+ Follow
Receivables
$18.52M
↑ 31.45% YoYΔ $4.43M vs prior year quarter

Peer trimmed avg / median

Loading

Cannara Biotech Receivables History

Loading

Cannara Biotech vs. peers: Receivables Comparison

Loading

Cannara Biotech Receivables Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Cannara Biotech (LOVE.V) FAQ

Cannara Biotech (LOVE.V) currently reports a receivables of $19M as of May 2026. That compares with $14M in the prior-year period — up 31.4% year over year. Use the charts on this page to explore Cannara Biotech's receivables history and peer comparisons.

Cannara Biotech's receivables increased from $14M to $19M — a 31.4% year-over-year increase (period ending May 2026). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Cannara Biotech reported $19M in receivables as of May 2026. That compares with $14M in the prior-year period — up 31.4% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current receivables of $19M, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for Cannara Biotech, and consider following LOVE.V for alerts when major investors trade the stock.

Questions & Answers